Data from other cancers have shown that APOBEC3B is the primary enzyme responsible for APOBEC signature-related mutations15,16, whereas APOBEC3A seems to be inducing DNA damage via double-strand breaks to a higher extend than APOBEC3B17. Here, APOBEC3A is linked to cancer.